Product Information
RENOVA 0.02% CREAM is a brand product labeled by Bausch Health US LLC, priced at $4.6748 per GM under NDC 00187515060. Its NADAC has been published 51 times since May 14, 2014.
FDA first approved this application on Aug 31, 2000.
Strength
.2 mg/g
Manufacturer
Bausch Health US LLCNDC
00187515060
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/17/2025
Active Ingredients
TRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA021108FDA Approved
8/31/2000
On Market Since
8/31/2000
Pharmacological Classes
Price Statistics
The NADAC for RENOVA 0.02% CREAM has been published 51 times since May 14, 2014, and over the history we have for it it has risen 16.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6748 per GM |
|---|---|
| All-time high | $4.6748 (Oct 1, 2025) |
| All-time low | $3.9985 (May 14, 2014) |
| Median price | $3.9985 |
| Average price | $4.1444 |
| Largest weekly change | +16.9% (Jul 23, 2025) |
| Weeks tracked | 51 |
| Tracking since | May 14, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+16.9%
5Y
+16.9%
All
+16.9%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RENOVA 0.02% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for RENOVA 0.02% CREAM, manufactured by Bausch Health US LLC, is $4.6748 per GM (NDC 00187515060), effective Oct 1, 2025.
How has the price of RENOVA 0.02% CREAM changed over time?
Over the history we have for it, the NADAC for RENOVA 0.02% CREAM has risen 16.9%. It has been tracked across 51 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for RENOVA 0.02% CREAM?
Since May 14, 2014, the NADAC for RENOVA 0.02% CREAM has ranged from a low of $3.9985 (May 14, 2014) to a high of $4.6748 (Oct 1, 2025), with a median of $3.9985 per GM.
Are there cheaper alternatives to RENOVA 0.02% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RENOVA 0.02% CREAM, is $2.3556 per GM — about 50% below RENOVA 0.02% CREAM.
Who manufactures RENOVA 0.02% CREAM?
RENOVA 0.02% CREAM (NDC 00187515060) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.